Landscapes / Targets
GPRC5D
17 drugs act on GPRC5D, in 43 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs17
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Approved | 30 Jun 2027Phase 2 trial completes | |||
| How it works | An antibody | ||||
| Next date | 30 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Multiple Myeloma, Hematological Malignancies and 1 more | ||||
| Open drug page | |||||
— |
Innovent · Public 1801.HK |
Phase 3 | 31 Dec 2026Phase 2 trial completes | ||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Multiple Myeloma, Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Phase 3 | 14 Jun 2027Phase 2 trial completes | |||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 14 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Multiple Myeloma, Relapsed or Refractory Multiple Myeloma and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2027Phase 2 trial completes | |||
| Next date | Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
Gene therapy substances |
Bristol Myers Squibb · Public BMY |
Phase 3 | 30 Dec 2027Phase 3 trial completes | ||
| How it works | A gene therapy | ||||
| Next date | 30 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM) | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Nov 2026soonPhase 1/2 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed and/or Refractory Multiple Myeloma, Neoplasms, Plasma Cell and 13 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 15 Jun 2027Phase 1/2 trial completes | |||
| Next date | 15 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma, Primary Plasma Cell Leukemia | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma, Multiple Myeloma | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | 24 Jan 2028Phase 1/2 trial completes | ||
| Next date | 24 Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1/2 | 20 Sep 2029Phase 1/2 trial completes | |||
| Next date | 20 Sep 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed/Refractory Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2027Phase 1 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | 28 Mar 2028Phase 1 trial completes | |||
| Next date | 28 Mar 2028 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
— |
Umoja Biopharma · Private |
Phase 1 | 31 Dec 2029Phase 1 trial completes | ||
| Next date | 31 Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma in Relapse, Multiple Myeloma (MM) | ||||
| Open drug page | |||||
— |
Phase 1 | 16 May 2031Phase 1 trial completes | |||
| Next date | 16 May 2031 · Phase 1 trial completes | ||||
| Also tested for | Plasma Cell Myeloma Refractory | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 17 of 17 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026